Exact Sciences
EXAS
#1906
Rank
ยฃ6.37 B
Marketcap
ยฃ34.34
Share price
3.42%
Change (1 day)
-32.35%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -ยฃ0.81 Billion

According to Exact Sciences's latest financial reports the company's current earnings are ยฃ2.75 Billion. a decrease over its 2023 earnings that were of -ยฃ0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -ยฃ0.77 Billion435.08%
2023 -ยฃ0.15 Billion-69.28%
2022 -ยฃ0.47 Billion-25.55%
2021 -ยฃ0.63 Billion1.68%
2020 -ยฃ0.62 Billion271.17%
2019 -ยฃ0.17 Billion58.99%
2018 -ยฃ0.11 Billion20.89%
2017 -ยฃ86.13 Million-30.95%
2016 -ยฃ0.13 Billion5.09%
2015 -ยฃ0.12 Billion57.24%
2014 -ยฃ75.49 Million116.53%
2013 -ยฃ34.87 Million
2011 -ยฃ21.71 Million143.73%
2010 -ยฃ8.91 Million27.85%
2009 -ยฃ6.97 Million0.27%
2008 -ยฃ6.95 Million-20.95%
2007 -ยฃ8.79 Million-13.53%
2006 -ยฃ10.17 Million-10.07%
2005 -ยฃ11.31 Million-21.81%
2004 -ยฃ14.46 Million-33.44%
2003 -ยฃ21.72 Million-6.51%
2002 -ยฃ23.23 Million17.95%
2001 -ยฃ19.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ90.82 Million-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ49.6 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ19.38 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ26.34 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.98 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France